Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001415889-24-010138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-03 | 2024-04-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $30.00 | -10.0K | 3,851 | -72% | -$300.0K |
| D | 2024-04-03 | 2024-04-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +10.0K | 10.0K | New | +$21.4K |
| D | 2024-04-03 | 2024-04-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $0.00 | -10.0K | 373.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | S | D | 2,851 | $31.02 | 1,000 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.73 to $31.46, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2024-04-01 | S | D | 1,000 | $31.95 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-01 | M | A | 10,000 | $2.14 | 10,000 | D | — | — | |
| 4 | Common | Common Stock | 2024-04-01 | S | D | 4,502 | $28.96 | 5,498 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.57 to $29.48, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2024-04-01 | S | D | 1,647 | $29.90 | 3,851 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.705 to $30.45, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-04-01 | M | D | 10,000 | $0.00 | 373,381 | D | $2.14 · — to 2031-04-01 | 10,000 Common Stock | (F5) A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter. |